Assessment of Menopause Related Quality of Life Among Health Professionals in University Hospitals of UMC in Nur-Sultan

January 25, 2021 updated by: Gauri Bapayeva, Nazarbayev University Medical Center
This study aims to investigate the quality of life of menopausal health-care providers in University Medical Center (UMC) hospitals in Nur-Sultan and identify whether there is a difference in the quality of life between two major groups of women health-care professionals: physicians and nurses, and to explore factors influencing on it.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Quality of life has turned into a reference for the so-called "state of wellbeing" that includes six domains: physical health, social relationships, psychological state, spiritual concerns, environmental features, and level of independence. Quality of life is perceived as a major health component, especially for menopausal women, and has become an essential research topic that has been discussed widely in the literature.

Therefore, from the HRQoL perspective, the consequences of the climacterium should be considered as a specific aspect of health-related quality of life in studies that include this segment of the population. The increased life expectancy of the general population and of women in particular, has turned women's health care in this phase of life into a priority; the way this should be accomplished, however, represents one of the main sources of public health debate.

Quality of work life is a comprehensive and general schema, which is essential in improving specialized personnel's satisfaction and attracting and preserving personnel. It also results in positive theories such as increasing profits and provocation. Nevertheless, although physicians and nurses are expected to provide patient care and improve their quality of life, their own needs and their own quality of life have been either largely underestimated or ignored.

Providing care in these cases is very demanding in physical, emotional, and spiritual terms. Their work requires certain qualities, such as empathy, compassion, and closeness to the individuals and families they care for. Therefore, daily work may be significantly influenced by the menopausal transition, especially in nurses and physicians Work is beneficial for menopausal women by providing fulfilment, self-esteem, identity and social needs. But working environments like those with lack of temperature control, cramped conditions, some uniforms and stress can also make menopause symptoms worse. Menopause refers to the time when a woman's menstrual period stops for 12 consecutive months after the last period and is characterized by a decline in the production of the ovarian hormones, mainly estrogen and progesterone. The lack of these hormones makes some women prone to experiencing common symptoms that include, but are not limited to, sleep disorders, mood alterations, hot flashes, depression, urinary tract infections, vaginal infections, and increased risk for osteoporosis and cardiovascular diseases. Providing up-to-date information to women about menopause, its management, and the use of menopausal hormone therapy (MHT) may serve as an important step towards treating postmenopausal symptoms thereby improving the QOL of postmenopausal women.

According to a recent study, the level of awareness and knowledge of women about the menopause is directly proportional to their ability to control their symptoms as menopausal symptoms can have a negative impact on work but menopause in the workplace still remains a taboo. This study aims to investigate the QoL of menopausal health-care providers in UMC hospitals in Nur-Sultan and identify whether there is a difference in the quality of life between two major groups of women health-care professionals: physicians and nurses, and to explore factors influencing on it.

Study Type

Observational

Enrollment (Anticipated)

320

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 64 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Since this study is aimed to investigate and determine the quality of life in menopausal women, the participants are menopausal women aged 45 years and older.

Description

Inclusion Criteria:

  • We will include all menopausal health-care providers working in CAD of Women's Health and Pediatric CAD UMC, NCCR, and RDC, Nur-Sultan Kazakhstan. In order to get the highest possible response rate as well as evaluate the non-response bias, there is a need to follow-up to those who did not responded.

Exclusion Criteria:

  • Women with serious health problems, such as severe chronic diseases, including psychological/psychiatric comorbidities, and use of specific drugs for them, will not be included in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Study group
Female health-care givers aged 45 to 64 years. The study participants will be recruited from UMC (Clinical Academic Department (CAD) of Women's Health, Pediatric Clinical Academic Department, Republic Diagnostic Center (RDC) and National Center for Children's Rehabilitation (NCCR)), Nur-Sultan, Kazakhstan.
The first part will assess the sociodemographic variables and reproductive characteristics, and the second part contain the Menopause-Specific Quality of Life (MENQOL) questionnaire The 29 questions of the MENQOL are divided into four domains: vasomotor (items 1-3), psychosocial (items 4-10), physical (items 11-26), and sexual (items 27-29).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Menopause Quality of Life Measurement
Time Frame: 36 month
The participants will be asked to indicate whether they had experienced symptoms or problems within the past month and, if so, to rate how bothersome they were on a seven-point Likert scale from 0 to 6: with 0 indicating that they were not at all bothered and 6 indicating that they were extremely bothered. The 29 questions of the MENQOL (supported by NCBI and NHI) are divided into four domains: vasomotor (items 1-3), psychosocial (items 4-10), physical (items 11-26), and sexual (items 27-29).
36 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Milan Terzic, MD, PhD, Nazarbayev University Medical Center
  • Study Director: Sanja Terzic, MD, Nazarbayev University Medical Center
  • Principal Investigator: Gauri Bapayeva, MD, PhD, Nazarbayev University Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

September 1, 2021

Primary Completion (ANTICIPATED)

February 1, 2023

Study Completion (ANTICIPATED)

August 1, 2024

Study Registration Dates

First Submitted

January 22, 2021

First Submitted That Met QC Criteria

January 22, 2021

First Posted (ACTUAL)

January 26, 2021

Study Record Updates

Last Update Posted (ACTUAL)

January 27, 2021

Last Update Submitted That Met QC Criteria

January 25, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 024-2020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Menopause

Clinical Trials on Survey

3
Subscribe